Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
07/20/2004 | US6765019 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids |
07/20/2004 | US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases |
07/20/2004 | US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation |
07/20/2004 | US6765011 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
07/20/2004 | US6765008 Pyrrolopyrimidines as CRF antagonists |
07/20/2004 | US6765006 Antagonists of amino-3-hydroxy-5-methylisoxazole-4-propionic acid (ampa) ionotropic receptors; neurodegenerative, alzheimer's, and huntington's disease; amyotrophic lateral sclerosis; schizophrenia, excitatory amino acid deficiency |
07/20/2004 | CA2042640C Barbiturate assay, tracers, immunogens, antibodies and kit |
07/15/2004 | WO2004058761A1 Pyrazole compounds as integrin receptor antagonists derivatives |
07/15/2004 | WO2004058755A2 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors |
07/15/2004 | WO2004058746A1 Substituted benzodioxepins |
07/15/2004 | WO2004058743A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors |
07/15/2004 | WO2004058741A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
07/15/2004 | WO2004058730A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
07/15/2004 | WO2004058727A1 Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity |
07/15/2004 | WO2004058722A1 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a |
07/15/2004 | WO2004058721A2 Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
07/15/2004 | WO2004058720A2 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor |
07/15/2004 | WO2004058718A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors |
07/15/2004 | WO2004058717A1 Isoquinolinone derivatives and their use as therapeutic agents |
07/15/2004 | WO2004058716A1 Substituted 4-aryl pyridines used as kiss-1 antagonists |
07/15/2004 | WO2004058713A1 Differential tumor cytotoxocity compounds and compositions |
07/15/2004 | WO2004058709A1 Ccr8 inhibitors |
07/15/2004 | WO2004058705A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
07/15/2004 | WO2004058702A2 4-[(4-(carboxyethyl) piperidinyl) methyl] pyrrolidines as modulators of chemokine receptor activity |
07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
07/15/2004 | WO2004058270A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases |
07/15/2004 | WO2004058265A1 Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors |
07/15/2004 | WO2004058264A1 Compound libraries of 2h-spiro (isoquinoline-1, -piperidine derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor |
07/15/2004 | WO2004058263A1 Compound libraries of 2, 3, 4, 9-tetrahydrospiro (beta-carboline-1, 4 -piperidine) derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor |
07/15/2004 | WO2004058259A1 Compound libraries of n-(aminocarbonyl)-piperidine-4-carboxamide derivatives capable of binding to g-protein coupled receptors |
07/15/2004 | WO2004058174A2 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
07/15/2004 | WO2004058144A2 Antibacterial agents |
07/15/2004 | WO2004050621A3 Indol derivatives and their use as kinase inhibitors |
07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
07/15/2004 | WO2004043918A3 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
07/15/2004 | WO2004043366A3 Sulfonamides |
07/15/2004 | WO2004039780A8 Novel alkyne compounds having an mch antagonistic effect and medicaments containing these compounds |
07/15/2004 | WO2004033632A3 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
07/15/2004 | WO2004032848A3 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
07/15/2004 | WO2004032846A3 Triazolone and triazolethione derivatives |
07/15/2004 | WO2004006846A3 Receptor-type kinase modulators and methods of use |
07/15/2004 | WO2004004714A1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
07/15/2004 | WO2003086294A3 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
07/15/2004 | WO2003011853A8 6-aryl-4-aminopicolinates and their use as herbicides |
07/15/2004 | US20040138460 Hydrolysis of phenylcarbamate of paroxetine in solvent |
07/15/2004 | US20040138289 Quaternary ammonium compounds |
07/15/2004 | US20040138286 Rho kinase inhibitors |
07/15/2004 | US20040138283 Deep vein thrombosis, noninsulin dependent diabetes, atherosclerosis, and pulmonary fibrosis treatment; cardiovascular and brain disorders |
07/15/2004 | US20040138276 Metalloproteinase inhibitors |
07/15/2004 | US20040138267 Antitumor agents |
07/15/2004 | US20040138266 Reacting 2-aminomethylchromam with ( 4-fluoropyriyl) pyridine-3-carbaldehyde |
07/15/2004 | US20040138265 Carboxamides as fungicides in agriculture |
07/15/2004 | US20040138259 Pain management |
07/15/2004 | US20040138240 Antitumor agents |
07/15/2004 | US20040138229 Platelet adenosine diphosphate receptor antagonists |
07/15/2004 | US20040138228 Novel compounds with analgesic effect |
07/15/2004 | US20040138227 Antiserotonine agents; antidepressants |
07/15/2004 | US20040138225 Analgesics; gastrointestinal disorders; central nervous system injuries |
07/15/2004 | US20040138223 Novel amide derivatives and medicinal use thereof ugs |
07/15/2004 | US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents |
07/15/2004 | US20040138205 Viricides; hepatitis virus |
07/15/2004 | US20040135871 Indolylphthalide compound and thermal recording material using the same |
07/15/2004 | US20040135130 Nonlinear optical compounds and methods for their preparation |
07/15/2004 | DE10300017A1 Selektive MMP 13 Inhibitoren Selective MMP inhibitors 13 |
07/15/2004 | DE10300015A1 Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen Iminosäurederivate as inhibitors of matrix metalloproteinases |
07/15/2004 | CA2511349A1 New substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
07/15/2004 | CA2511235A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors |
07/15/2004 | CA2511199A1 Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
07/15/2004 | CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
07/15/2004 | CA2507958A1 Pyrazole compounds as integrin receptor antagonists derivatives |
07/15/2004 | CA2485375A1 Spirocyclic piperidines as mch1 antagonists and uses thereof |
07/14/2004 | EP1437353A1 Alkyl ether derivatives or salts thereof |
07/14/2004 | EP1437352A1 Benzimidazole compound, process for producing the same, and use thereof |
07/14/2004 | EP1437348A1 6-methyl-2,4-diamino-pyrimidine derivatives, process for preparation, compositions containing them and their uses as basic neutralising agents |
07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
07/14/2004 | EP1436286A1 Fumagillol derivatives and preparing method thereof |
07/14/2004 | EP1436272A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
07/14/2004 | EP1436267A1 Lactam derivatives as antagonists for human 11cby receptors |
07/14/2004 | EP1436266A2 Methods and compositions of novel triazine compounds |
07/14/2004 | EP1436265A2 Chemical compounds |
07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
07/14/2004 | EP1435974A2 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
07/14/2004 | EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
07/14/2004 | EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
07/14/2004 | EP1435947A1 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cds1/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
07/14/2004 | EP1435944A1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
07/14/2004 | EP1435934A1 5'-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
07/14/2004 | EP1228067B1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
07/14/2004 | EP1110961B1 Oxygenic heterocyclic compounds |
07/14/2004 | EP1077940B1 4-phenylpiperidines for the treatment of pruritic dermatoses |
07/14/2004 | CN1513175A Optical data carrier that contains merocyanine dye as light-absorbing compound in the information layer |
07/14/2004 | CN1513173A Optical data carrier containing a cyclizable compound in the information layer |
07/14/2004 | CN1512985A Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands |
07/14/2004 | CN1511832A Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives |
07/14/2004 | CN1511830A Compound used as antiphlogistic |
07/14/2004 | CN1511820A Novel intemediate for preparing 4-hydroxy-2-oxygen-pyran derivatives as protease inhibitor |
07/14/2004 | CN1157384C 2,4-diamino-1,3,5-triazines, process for production, and use thereof as herbicides and plant growth regulators |
07/14/2004 | CN1157382C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents cnotaining these compounds |